P-selectin and sST2 as prognostic biomarkers of cardiovascular events in patients with multiple myeloma following anticancer therapy and severe COVID-19
This study investigates the prognostic value of sST2 and P-selectin as biomarkers for cardiovascular risk in patients with multiple myeloma (MM) who are in remission following anticancer therapy and have experienced severe COVID-19. The topic is of increasing clinical relevance due to the growing in...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Zaporizhzhia State Medical and Pharmaceutical University
2025-07-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Assuntos: | |
| Acceso en liña: | https://pharmed.zsmu.edu.ua/article/view/329039/323378 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|